Eric Dishman, vice president and Intel fellow of Intel's Health and Life Sciences Group, has been tapped by the National Institutes of Health to become director of the Precision Medicine Initiative Cohort Program. 

A recent study in the American Journal of Managed Care found evidence that reductions in specialty drug utilization were associated with higher cost sharing, with the effects varying by the type of disease and outcome of the drug in use.

Findings from the World Health Organization suggest every U.S. dollar invested in mental health treatment can quadruple returns in work productivity. However, most countries are investing far below what is needed for those suffering from common mental disorders.

Venture capital funding, including private equity and corporate venture capital, in the health IT sector increased 27 percent quarter over quarter, coming in at $1.4 billion in 146 deals compared to $1.1 billion in 145 deals in Q4 2015, according to a Mercom Capital Group report. 

OSF HealthCare has launched OSF Ventures designed to strategically invest in new technology and devices that can transform and improve healthcare. 

Tech billionaire Sean Parker announced a $250 million grant for cancer immunotherapy research that will include 40 laboratories and 300 researchers from six top cancer centers.

Researchers believe they may have found real-life men and women of “steel”—genetically speaking, that is—who have survived and thrived despite genetic mutations that should have resulted in serious and possibly deadly childhood diseases, according to results of a study recently published in Nature Biotechnology.

IBM and the American Cancer Society (ACS) have partnered to create the first advisor for people fighting cancer, powered by Watson cognitive computing.